Your activity: 2 p.v.

Induction therapy choice based on risk assessment

Induction therapy choice based on risk assessment
HLA: human leukocyte antigen.
From: Hardinger KL, Brennan DC, Klein CL. Selection of induction therapy in kidney transplantation. Transpl Int 2013; 26(7):662-72. http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12043/abstract. Copyright © 2013 European Society for Organ Transplantation. Reproduced with permission of Blackwell Publishing Ltd. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department either via email: permissions@wiley.com or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (http://onlinelibrary.wiley.com).
Graphic 108391 Version 2.0